Yuming Rong

529 total citations
43 papers, 350 citations indexed

About

Yuming Rong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yuming Rong has authored 43 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Yuming Rong's work include Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Yuming Rong is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Yuming Rong collaborates with scholars based in China, Ethiopia and United States. Yuming Rong's co-authors include Wenzhuo He, Huijuan Qiu, Bei Zhang, Guifang Guo, Chenxi Yin, Chang Jiang, Liangping Xia, Liangping Xia, Xuxian Chen and Yifeng Zou and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yuming Rong

40 papers receiving 348 citations

Peers

Countries citing papers authored by Yuming Rong

Since Specialization

Citations

This map shows the geographic impact of Yuming Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuming Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuming Rong more than expected).

Fields of papers citing papers by Yuming Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuming Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuming Rong. The network helps show where Yuming Rong may publish in the future.

Co-authorship network of co-authors of Yuming Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Yuming Rong. A scholar is included among the top collaborators of Yuming Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuming Rong. Yuming Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study 2025 ·Nutrients ·(unknown), (unknown), (unknown), PengXin Zhang, (unknown), Suping Guo, (unknown), Daquan Wang, Qingping Wu, Hui Liu, Yuming Rong, Bo Qiu	0
2	Association of modifiable risk factors and telomere length with five neuroendocrine neoplasms: a bidirectional Mendelian randomization study 2025 ·Discover Oncology ·(unknown), (unknown), (unknown), Yuming Rong, Xuxian Chen, Mengge Gao, Jinsheng Huang	0
3	Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study 2024 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), (unknown), PengXin Zhang, (unknown), (unknown), Li Chen, (unknown), (unknown), Yuming Rong, Hui Liu, Bo Qiu	3
4	Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations 2023 ·Cancer Medicine ·Jinsheng Huang, (unknown), (unknown), (unknown), Qi Jiang, (unknown), Yuming Rong, Guifang Guo	17
5	Efficacy of Aidi injection combined with chemotherapy, radiotherapy or chemoradiotherapy for unresectable esophageal cancer treatment: A meta-analysis and systematic review of 29 randomized controlled trials based on Asian populations (China) 2023 ·European Journal of Clinical Pharmacology ·Jinsheng Huang, (unknown), Yuming Rong, (unknown), (unknown), (unknown), (unknown), (unknown), Bei Zhang, Guifang Guo	4
6	Crohn’s disease patients with L4-esophagogastroduodenal phenotype is associated with a better prognosis: A retrospective cohort study 2022 ·Frontiers in Pharmacology ·(unknown), Xutao Lin, Xi Chen, (unknown), Yucheng Xu, Jiawei Cai, (unknown), Yuming Rong, Yifeng Zou, (unknown)	3
7	Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection 2022 ·Annals of Surgical Oncology ·Long Bai, Xiaoluan Yan, Yun‐Xin Lu, Qi Meng, Yuming Rong, (unknown), Zhizhong Pan, Baocai Xing, De‐Shen Wang	4
8	He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway 2021 ·Phytomedicine ·(unknown), (unknown), Rui-Sheng Zhou, Dai-Han Zhou, Yu-Fang Huang, Hongwei Zhao, Yunlong Zhang, Yuming Rong, Jun Dong, Liangping Xia, Shanshan Liu, Qiuling Huang, Nannan Wang, Ning Na, Bei Zhang, Enxin Zhang	21
9	MET exon 14 skipping mutation, amplification and overexpression in pulmonary sarcomatoid carcinoma: A multi-center study 2020 ·Translational Oncology ·Xuewen Liu, (unknown), Yuming Rong, Ning Lyu, C. Xu, Fang Wang, Wenyong Sun, (unknown), Jingping Yuan, Huijuan Wang, Wenxian Wang, Wenbin Huang, Jianping Xu, (unknown), Likun Chen	16
10	Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer 2020 ·Oral Oncology ·Wenzhuo He, Chang Jiang, Lili Liu, Chenxi Yin, Yuming Rong, Wanming Hu, Lin Yang, Lei Wang, (unknown), Xiaoping Lin, Shousheng Liu, Jinsheng Huang, Shasha He, Yuqing Liang, Huijuan Qiu, Bei Zhang, Wei Fan, Guifang Guo, Qiuxia Yang, Liangping Xia	26
11	Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease 2019 ·Journal of Cancer ·Qi Quan, (unknown), Shousheng Liu, Ping Chen, Wenzhuo He, Yuanyuan Huang, Yuming Rong, Huijuan Qiu, Bei Zhang, (unknown)	11
12	A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients 2019 ·Cancer Cell International ·Yifeng Zou, Yuming Rong, (unknown), Jian Xiao, Zhaoliang Yu, Yufeng Chen, Jia Ke, Yuezhe Li, Xi Chen, Xiaojian Wu, Ping Lan, Xutao Lin, Feng Gao	19
13	Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients 2018 ·Journal of Translational Medicine ·Shousheng Liu, Yuanzhong Yang, Chang Jiang, Qi Quan, Qiankun Xie, (unknown), Wenzhuo He, Yuming Rong, Ping Chen, Qiong Yang, Lin Yang, Bei Zhang, Xiaojun Xia, Pengfei Kong, Liangping Xia	16
14	Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data 2018 ·PLoS ONE ·Guifang Guo, Xiuxing Chen, Wenzhuo He, (unknown), Yixing Wang, (unknown), Yuming Rong, Lei Fan, Liangping Xia	14
15	Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis 2017 ·Translational Oncology ·Qi Quan, Yuanyuan Huang, (unknown), Huijuan Qiu, (unknown), Yuming Rong, Tingwei Li, Liangping Xia, Bei Zhang	20
16	Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients 2016 ·OncoTargets and Therapy ·Chang Jiang, Wanming Hu, (unknown), Qiong Yang, Ping Chen, Yuming Rong, Guifang Guo, Chenxi Yin, Bei Zhang, Wenzhuo He, Liangping Xia	15
17	A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C 2015 ·OncoTargets and Therapy ·(unknown), Wenzhuo He, Chang Jiang, Chenxi Yin, Guifang Guo, Xuxian Chen, Huijuan Qiu, Yuming Rong, Bei Zhang, Dazhi Xu, Liangping Xia	30
18	Efficacy of Taxane-Based Regimens in a First-line Setting for Recurrent and/or Metastatic Chinese Patients with Esophageal Cancer 2014 ·Asian Pacific Journal of Cancer Prevention ·Chang Jiang, (unknown), Yuming Rong, Qiong Yang, Chenxi Yin, Wenzhuo He, Xiuyu Cai, Guifang Guo, Huijuan Qiu, Xuxian Chen, Bei Zhang, Liangping Xia	5
19	Lymph Node Ratio and pN Staging Show Different Superiority As Prognostic Predictors Depending on the Number of Lymph Nodes Dissected in Chinese Patients With Luminal A Breast Cancer 2012 ·Clinical Breast Cancer ·Fang Wang, Wenzhuo He, Huijuan Qiu, Xi Wang, Guifang Guo, Xuxian Chen, Yuming Rong, Feifei Zhou, Chenxi Yin, Zhongyu Yuan, Liangping Xia	13
20	Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases 2009 ·Chinese Journal of Cancer ·Liangping Xia, Bei Zhang, (unknown), (unknown), Xuxian Chen, Guifang Guo, Huijuan Qiu, Yuming Rong, (unknown), Feifei Zhou, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact